Friday 6 November 2026 Export ABCL’s income statement to Excel — free account

AbCellera Biologics Inc.

AbCellera Biologics Inc.’s revenue for fiscal 2025 (year ended December 2025) was $75.1 million, up 160.6% from fiscal 2024.

Revenue: −76.3%
EPS: −50.0%
Free cash flow: +152.0%

Quarter to June 2026, against a year earlier

Insider buying

11.89 0.76 +6.83%

Follow ABCL

Alert me

Market cap: $3.6B
P/E: 0.0×
Fwd P/E: −18.4×
Dividend yield: —
F-score: 5/9
Altman Z: 1.66
Beneish M: −1.06
Dividend safety: n/a

Overview

AbCellera Biologics Inc. (ABCL) P/E ratio

Alert me on P/E ratio

AbCellera Biologics Inc. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 5,890× (December 2020) — the current reading is the lowest in ten years.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/ABCL/pe-ratio" width="100%" height="360" style="border:0" loading="lazy" title="AbCellera Biologics Inc. P/E ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/ABCL/metrics/pe-ratio">AbCellera Biologics Inc. (ABCL) P/E ratio — stockrow.com</a></p>

Period	P/E ratio	Change
FY2025	0.0×	—
FY2024	0.0×	—
FY2023	0.0×	—
FY2022	16.9×	(34.82%)
FY2021	26.0×	(51.73%)
FY2020	53.9×	(99.09%)
FY2019	5,890×	0.00%
FY2018	5,890×	—

Period	P/E ratio	Change
Jun 2026	0.0×	—
Mar 2026	0.0×	—
Dec 2025	0.0×	—
Sep 2025	0.0×	—
22 more quarters	Free account

Against its own ten years

Low 0.0× High 5,890×

Ten-year median 0.0×

Current reading's percentile 61

Company	P/E ratio
TNGX Tango Therapeutics, Inc. compare	n/m
PBLS Parabilis Medicines, Inc. compare	n/m
EWTX Edgewise Therapeutics, Inc. compare	n/m
ABCL AbCellera Biologics Inc.	n/m
IOVA Iovance Biotherapeutics, Inc. compare	n/m
RLAY Relay Therapeutics, Inc. compare	n/m
XENE Xenon Pharmaceuticals Inc. compare	n/m
ACAD ACADIA Pharmaceuticals Inc. compare	10.0×
ARQT Arcutis Biotherapeutics, Inc. compare	119×
Biotechnology industry median	10.3×
Healthcare sector median	25.2×
Market median	17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

AbCellera Biologics Inc. (ABCL) P/E ratio

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on ABCL

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on ABCL

Stockrow Weekly